Manguilimotan, Nicha .
HRN: 28-32-65 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2025
CEFUROXIME 500MG (TAB)
12/25/2025
01/01/2026
ORAL
500 Mg
Bid
S/p Nsvd
Checking Initial Appropriateness